Clinical Trials Logo

Clinical Trial Summary

The objetive of this study is to determine the minimum amount of Alternaria alternata allergen extract producing in a positive skin reaction.


Clinical Trial Description

This is an open, unblinded and non-randomized biological assay. The primary objective is to assess the concentration of alternaria alternata allergen extract that elicits a wheal size equivalent to that of a 10 mg/ml histamine dyhidrochloride solution. ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01984528
Study type Interventional
Source Laboratorios Leti, S.L.
Contact
Status Completed
Phase Phase 2
Start date February 2014
Completion date December 2014